Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425086 · ClinicalTrials.gov registry record
Clinical Performance of the Embrace Isothermal Mattress
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 36
- Enrollment target
NCT01425086: Completed study, sponsored by Stanford University.
NCT01425086 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425086 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the performance of a new warming technology (Embrace Isothermal Mattress) during the thermal weaning of premature infants from incubators to open cribs. The investigators aim to study the Embrace Isothermal Mattress over a 24-hour period before the infant is transitioned out of the incubator.
Primary Outcome
As monitored by ambient (environmental) temperature, infant's core and surface temperature
Interventions
- DEVICE Embrace, PCM, warming blanket
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-12-31 |
What the finished NCT01425086 record still lists
NCT01425086 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Embrace, PCM, warming blanket is the first listed.
NCT01425086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01425086 about?
NCT01425086 is a clinical study titled "Clinical Performance of the Embrace Isothermal Mattress". The purpose of this pilot study is to evaluate the performance of a new warming technology (Embrace Isothermal Mattress) during the thermal weaning of premature infants from incubators to open cribs. The investigators aim to study the Embrace Isothermal Mattress over a 24-hour period before the infa...
What is the current status of trial NCT01425086?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2011-03. Estimated completion is 2012-12-31.
What interventions are being tested in trial NCT01425086?
The interventions under investigation include: Embrace, PCM, warming blanket (DEVICE).
Who is sponsoring clinical trial NCT01425086?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia